36946-70-0

Basic information

• Product Name: 2-Aminoindole hydrochloride
• Synonyms: 1H-INDOL-2-AMINE HCL;2-AMINOINDOLE, HYDROCHLORIDE;1H-indol-2-aMine hydrochloride;2-AMinoindoleHCL
• CAS NO: 36946-70-0
• Molecular Formula: C₈H₈N₂
• Molecular Weight: 168.62
• Product Categories: Nitrogen cyclic compounds;Indole Derivatives;Heterocycle-Indole series
• Mol File: 36946-70-0.mol

Chemical Properties

• Melting Point: 215-220°C dec.
• Boiling Point: 372.4°C at 760 mmHg
• Flash Point: 179°C
• Appearance: /
• Density: 1.268±0.06 g/cm3(Predicted)
• Vapor Pressure: 6.6E-06mmHg at 25°C
• Storage Temp.: Hygroscopic, -20°C Freezer, Under Inert Atmosphere
• Solubility: DMSO (Slightly), Methanol (Slightly), Water (Slightly)
• PKA: 18.89±0.30(Predicted)
• CAS DataBase Reference: 2-Aminoindole hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Aminoindole hydrochloride(36946-70-0)
• EPA Substance Registry System: 2-Aminoindole hydrochloride(36946-70-0)

Safety Data

• Hazardous Substances Data: 36946-70-0(Hazardous Substances Data)

Usage

Chemical Properties

Pale Brown Solid

InChI:InChI=1/C8H8N2.ClH/c9-8-5-6-3-1-2-4-7(6)10-8;/h1-5,10H,9H2;1H

Synthetic route

(1H-indol-1-yl)(pyridin-2-yl)methanone (1131148-08-7) → indoleamine (36946-70-0)

Conditions	Yield
Stage #1: (1H-indol-1-yl)(pyridin-2-yl)methanone With tert.-butylnitrite; copper diacetate In 1,4-dioxane at 70℃; for 16h; Stage #2: With hydrazine hydrate; FeCl3/C In 1,4-dioxane; ethanol at 70℃;	93%

2-nitroindole (193686-70-3) → indoleamine (36946-70-0)

Conditions	Yield
With sodium tetrahydroborate In water at 60℃; for 0.25h; Sonication;	88%

2-nitro-benzeneacetonitrile (610-66-2) → indoleamine (36946-70-0)

Conditions	Yield
With hydrogenchloride In ethanol at 30℃; for 3h;	52%

2-methyl-2-pyrrolidin-1-yl-propan-1-ol (101258-96-2) + 5-Hydroxy-2-methyl-1H-indole-3-carboxylic acid benzyl ester (27667-51-2) + Toluene-2-sulfonyl chloride (133-59-5) → indoleamine (36946-70-0) + 2-Methyl-5-(2-methyl-2-pyrrolidin-1-yl-propoxy)-1H-indole-3-carboxylic acid benzyl ester (459449-48-0)

Conditions	Yield
With potassium carbonate; triethylamine; trifluoroacetic acid In acetonitrile	A n/a B 5%

2-aminophenylacetonitrile (2973-50-4) + sodium ethanolate (141-52-6) + hydrogen → indoleamine (36946-70-0)

(2-formylamino-phenyl)-acetonitrile (861571-31-5) + potassium carbonate → indoleamine (36946-70-0)

indoleamine (36946-70-0) + 1-Phenyl-4,4,4-trifluorobutane-1,3-dione (326-06-7) → 2-phenyl-4-(trifluoromethyl)-9H-pyrido[2,3-b]indole (869465-09-8)

Conditions	Yield
With acetic acid for 1h; Heating;	89%
With acetic acid for 2h; Inert atmosphere; Reflux; regiospecific reaction;	89%

indoleamine (36946-70-0) + sodium 5,5,6,6,6-pentafluoro-2,4-hexanedione (356-40-1) → 2-methyl 4-(perfluoroethyl)-9H-pyrido[2,3-b]indole (1190370-62-7)

Conditions	Yield
With acetic acid for 2h; Inert atmosphere; Reflux; regiospecific reaction;	87%

indoleamine (36946-70-0) + 1,1,1,5,5,5-hexafluoroacetylacetone (1522-22-1) → 2,4-bis(trifluoromethyl)-9H-pyrido[2,3-b]indole (869465-16-7)

Conditions	Yield
With acetic acid for 2h; Inert atmosphere; Reflux; regiospecific reaction;	86%

indoleamine (36946-70-0) + 1-Chlor-1,1-difluor-3-benzoyl-aceton (2062-21-7) → 4-(chlorodifluoromethyl)-2-phenyl-9H-pyrido[2,3-b]indole (869465-10-1)

Conditions	Yield
With acetic acid for 2h; Inert atmosphere; Reflux; regiospecific reaction;	85%

indoleamine (36946-70-0) + 1,1,1-Trifluoro-2,4-pentanedione (367-57-7) → 2-methyl-4-(trifluoromethyl)-9H-pyrido[2,3-b]indole (1018966-60-3)

Conditions	Yield
With acetic acid for 1h; Heating;	84%
With acetic acid for 2h; Inert atmosphere; Reflux; regiospecific reaction;	84%

indoleamine (36946-70-0) + 1,1-difluoro-1-phenyl-1,3-butanedione (41739-23-5) → 4-(difluoromethyl)-2-methyl-9H-pyrido[2,3-b]indole (1018966-65-8)

Conditions	Yield
With acetic acid for 2h; Inert atmosphere; Reflux; regiospecific reaction;	81%

indoleamine (36946-70-0) + α-(2,2,2-trifluoroacetyl)-δ-valerolactone → 3-(3-hydroxypropyl)-4-(trifluoromethyl)-1,9-dihydro-2H-pyrido[2,3-b]indol-2-one (1190370-42-3)

Conditions	Yield
With acetic acid for 2h; Inert atmosphere; Reflux; regiospecific reaction;	74%

indoleamine (36946-70-0) + 3-[(2-chlorophenyl)hydrazono]pentane-2,4-dione (24756-05-6) → 3-(2-chlorophenyldiazenyl)-2,4-dimethyl-9H-pyrido[2,3-b]indole

Conditions	Yield
With pyridine at 20℃; for 72h;	68%

indoleamine (36946-70-0) + perfluorobenzaldehyde (653-37-2) → 1,2,3,4-tetrafluoro-6H-indolo[2,3-b]quinoline (1190370-41-2) + C15H10F5N3

Conditions	Yield
With acetic acid In N,N-dimethyl-formamide Inert atmosphere; Reflux; regiospecific reaction;	A 67% B n/a

indoleamine (36946-70-0) + 2-(2,2,2-trifluoroacetyl)-3,4-dihydro-2H-naphthalen-1-one (318-46-7) → 7-(trifluoromethyl)-6,12-dihydro-5H-12,13-diazaindeno[1,2-b]phenanthrene (869465-12-3)

Conditions	Yield
With acetic acid for 2h; Inert atmosphere; Reflux; regiospecific reaction;	64%

indoleamine (36946-70-0) + S-ketoprofen (22161-81-5) → 2-(3-benzoylphenyl)-N-(1H-indol-2-yl)propanamide (1239447-49-4)

Conditions	Yield
Stage #1: S-ketoprofen With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 0.5h; Stage #2: indoleamine In N,N-dimethyl-formamide at 20℃; for 2h;	62%

indoleamine (36946-70-0) + benzaldehyde (100-52-7) → 2,4-diphenyl-5H-pyrimido[5,4-b]indole (56807-26-2)

Conditions	Yield
With ammonium iodide; oxygen; sodium hydrogencarbonate; dimethyl sulfoxide In chlorobenzene at 140℃; for 16h; Molecular sieve; Inert atmosphere;	57%

indoleamine (36946-70-0) + 3-(2-(4-bromophenyl)hydrazineylidene) pentane-2,4-dione (24756-09-0) → 3-(4-bromophenyldiazenyl)-2,4-dimethyl-9H-pyrido[2,3-b]indole

Conditions	Yield
With pyridine at 20℃; for 72h;	51%

indoleamine (36946-70-0) + pentane-2,3,4-trione 3-[(3-nitro-phenyl)-hydrazone] (3490-72-0) → 2,4-dimethyl-3-(3-nitrophenyldiazenyl)-9H-pyrido[2,3-b]indole

Conditions	Yield
With pyridine at 20℃; for 72h;	50%

3-[(2-bromo-phenyl)-hydrazono]-pentane-2,4-dione + indoleamine (36946-70-0) → 3-(2-bromophenyldiazenyl)-2,4-dimethyl-9H-pyrido[2,3-b]indole

Conditions	Yield
With pyridine at 20℃; for 72h;	49%

indoleamine (36946-70-0) + 4-ethyl 4-(2-(2,4-dioxopentan-3-ylidene)hydrazineyl)benzoate (41095-26-5) → ethyl 4-(2,4-dimethyl-9H-pyrido[2,3-b]indol-3-yldiazenyl)benzoate

Conditions	Yield
With pyridine at 20℃; for 72h;	48%

3-[(2-iodo-phenyl)-hydrazono]-pentane-2,4-dione + indoleamine (36946-70-0) → 3-(2-iodophenyldiazenyl)-2,4-dimethyl-9H-pyrido[2,3-b]indole

Conditions	Yield
With pyridine at 20℃; for 72h;	45%

indoleamine (36946-70-0) + benzoyl chloride (98-88-4) → 2-(benzoylamino)indole (92264-37-4) + 1-benzoyl-2-benzamidoindole

Conditions	Yield
With pyridine; dmap for 1h; Ambient temperature;	A 35% B 14%

indoleamine (36946-70-0) + C12H12O3 (1612153-85-1) → C20H16N2O (1612154-11-6)

Conditions	Yield
With (triphenylphosphine)gold(I) chloride; water; silver trifluoromethanesulfonate; toluene-4-sulfonic acid In 1,2-dichloro-ethane at 120℃; Michael Addition; Microwave irradiation;	34%

indoleamine (36946-70-0) + 1-(3-hydroperoxyprop-1-ynyl)-4-methoxybenzene (1416983-93-1) → 2-(4-methoxyphenyl)-9H-pyrido[2,3-b]indole (1175675-37-2) + C18H14N2O (1612154-12-7)

Conditions	Yield
With (triphenylphosphine)gold(I) chloride; water; silver trifluoromethanesulfonate; toluene-4-sulfonic acid In 1,2-dichloro-ethane at 120℃; Michael Addition; Microwave irradiation;	A 30% B 28%

indoleamine (36946-70-0) + ethyl 3-(ethoxymethylene)-2,4-dioxovalerate (57397-70-3) → ethyl 3-acetyl-9H-pyrimido<2,3-b>indole-4-carboxylate (77740-29-5)

Conditions	Yield
In ethanol for 2h;	28%

indoleamine (36946-70-0) + C9H7BrO2 (1416984-00-3) → C17H11BrN2 (1612154-09-2) + C17H11BrN2 (1612154-13-8)

Conditions	Yield
With (triphenylphosphine)gold(I) chloride; water; silver trifluoromethanesulfonate; toluene-4-sulfonic acid In 1,2-dichloro-ethane at 120℃; Michael Addition; Microwave irradiation;	A 26% B 23%

indoleamine (36946-70-0) + diethyl(ethoxymethylene)oxalacetate (52942-64-0) → diethyl 9H-pyrimido<2,3-b>indole-3,4-dicarboxylate (77740-30-8)

Conditions	Yield
In ethanol for 2h;	25%

indoleamine (36946-70-0) + C16H14O3 (1612153-84-0) → C24H18N2O (1612154-10-5) + C24H18N2O (1612154-14-9)

Conditions	Yield
With (triphenylphosphine)gold(I) chloride; water; silver trifluoromethanesulfonate; toluene-4-sulfonic acid In 1,2-dichloro-ethane at 120℃; Michael Addition; Microwave irradiation;	A 24% B 25%

indoleamine (36946-70-0) + 3-[(2-methylphenyl)hydrazono]pentane-2,4-dione (24756-03-4) → 2,4-dimethyl-3-(2-methylphenyldiazenyl)-9H-pyrido[2,3-b]indole

Conditions	Yield
With pyridine at 20℃; for 72h;	19%

indoleamine (36946-70-0) + (5α,17α)-17-hydroxy-2-(hydroxymethylene)pregn-20-yn-3-one (78094-38-9, 138231-82-0) → C30H34N2O (138091-32-4)

Conditions	Yield
In ethanol Heating;	18%

indoleamine (36946-70-0) + (5α,17α)-17-hydroxy-2-(hydroxymethylene)pregn-20-yn-3-one (78094-38-9, 138231-82-0) → C30H34N2O (138091-31-3)

Conditions	Yield
In ethanol Heating;	18%

Upstream product

• 2973-50-4 2-aminophenylacetonitrile 
• 141-52-6 sodium ethanolate 
• 861571-31-5 (2-formylamino-phenyl)-acetonitrile 
• 193686-70-3 2-nitroindole 
• 1131148-08-7 (1H-indol-1-yl)(pyridin-2-yl)methanone 
• 101258-96-2 2-methyl-2-pyrrolidin-1-yl-propan-1-ol 
• 27667-51-2 5-Hydroxy-2-methyl-1H-indole-3-carboxylic acid benzyl ester 
• 133-59-5 Toluene-2-sulfonyl chloride 
• 610-66-2 2-nitro-benzeneacetonitrile 

Downstream Products

• 271-26-1 3H-indole 
• 68006-83-7 3-Methyl-2-Amino-alpha-carboline 
• 79801-90-4 2-amino-3-propyl-9H-pyrido<2,3-b>indole 
• 79801-91-5 2-amino-3-butyl-9H-pyrido<2,3-b>indole 
• 79801-92-6 2-amino-3-amyl-9H-pyrido<2,3-b>indole 
• 79801-93-7 2-amino-3-benzyl-9H-pyrido<2,3-b>indole 
• 869465-09-8 2-phenyl-4-(trifluoromethyl)-9H-pyrido[2,3-b]indole 
• 1175675-37-2 2-(4-methoxyphenyl)-9H-pyrido[2,3-b]indole 
• 1612154-12-7 C₁₈H₁₄N₂O 
• 1612154-10-5 C₂₄H₁₈N₂O 
• 1612154-14-9 C₂₄H₁₈N₂O 
• 1612154-11-6 C₂₀H₁₆N₂O 
• 1612154-09-2 C₁₇H₁₁BrN₂ 
• 1612154-13-8 C₁₇H₁₁BrN₂ 

Relevant articles and documents

Fe3O4 – Glutathione stabilized Ag nanoparticles: A new magnetically separable robust and facile catalyst for aqueous phase reduction of nitroarenes

The heterostructured Ag nanoparticles decorated Fe3O4 Glutathione (Fe3O4-Glu-Ag) nanoparticles (NPs) were synthesized by sonicating glutathione (Glu) with magnetite and further surface immobilization of silver NPs on it. The ensuing magnetic nano catalyst is well characterized by Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), high resolution transmission electron microscopy (HRTEM), powder X-ray diffraction (PXRD), thermogravimetric analysis (TGA). The prepared Fe3O4-Glu-Ag nanoparticles have proved to be an efficient and recyclable nanocatalyst with low catalyst loading for the reduction of nitroarenes and heteronitroarenes to respective amines in the presence of NaBH4 using water as a green solvent which could be easily separated at the end of a reaction using an external magnet and can be recycled up to 5 runs without any significant loss in catalytic activity. Gram scale study for the reduction of 4-NP has also being carried out successfully and it has been observed that this method can serve as an efficient protocol for reduction of nitroarenes on industrial level.

Method for preparing 2-aminoindole derivative

The invention discloses a method for preparing a 2-aminoindole derivative. The method provided by the invention has the following advantages: pyridine formylindole is used as a starting material, so raw materials are easily-available and have extensive varieties; products obtained by the utilizing the method provided by the invention have various types and extensive use, and can be directly used and can be used for synthesis of drugs; in addition, the method disclosed by the invention has the advantages of simple steps, mild reaction conditions, high target product yield, less pollution, simple reaction operation and post-treatment process, and applicability to industrial production.

Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor

Disclosed are novel compounds having the formula or a physiologically acceptable salt, amide, ester or prodrug thereof. The compounds can be used to modulate (antagonize, agonize) chemokine receptor function. Also disclosed is a method for treating a patient having an inflammatory disease and/or viral infection comprising administering an effective amount of a compound of Formula I. In particular embodiments, the invention is a method for treating a patient infected with HIV.